Timo Carpén

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Topics

Cervical Cancer Screening

Epstein Barr Virus

Top Venues

Scientific reports

Acta oncologica (Stockholm, Sweden)

Cancer immunology, immunotherapy : CII

FASEB bioAdvances

This page only lists publications with an associated author ORCID identifier.

Publications

Rayan Mroueh, Aaro Haapaniemi, Timo Carpén, Eero Pukkala, Antti Aarni Mäkitie
Laryngeal cancer relative survival trends from 1972 to 2021 in the Nordic countries. Acta oncologica (Stockholm, Sweden) 63 (2024)
Rayan Mroueh, Aaro Haapaniemi, Timo Carpén, Eero Pukkala, Antti Aarni Mäkitie
Laryngeal cancer relative survival trends from 1972 to 2021 in the Nordic countries. Acta oncologica (Stockholm, Sweden) 63 (2024)
Reija Randén-Brady, Timo Carpén, Laura C Hautala, Tuomas Tolvanen, Caj Haglund, Sakari Joenväärä, Petri S Mattila, Antti Aarni Mäkitie, Sanna H Lehtonen, Jaana Hagstrom, Suvi Renkonen
LRG1 and SDR16C5 protein expressions differ according to HPV status in oropharyngeal squamous cell carcinoma. Scientific reports 14 (1) (2024)
Reija Randén-Brady, Timo Carpén, Laura C Hautala, Tuomas Tolvanen, Caj Haglund, Sakari Joenväärä, Petri S Mattila, Antti Aarni Mäkitie, Sanna H Lehtonen, Jaana Hagstrom, Suvi Renkonen
LRG1 and SDR16C5 protein expressions differ according to HPV status in oropharyngeal squamous cell carcinoma. Scientific reports 14 (1) (2024)
Rayan Mroueh, Timo Carpén, Johnni Hansen, Sanna M M Heikkinen, Neda Esmailzadeh Bruun-Rasmussen, Jan Ivar Martinsen, Jenny Selander, Ingrid Sivesind Mehlum, Jóhanna Eyrún Torfadóttir, Antti Aarni Mäkitie, Eero Pukkala
Socio-economic status and head and neck cancer incidence in the Nordic countries. International journal of epidemiology 53 (4) (2024)
Reija Randén-Brady, Timo Carpén, Laura C Hautala, Tuomas Tolvanen, Caj Haglund, Sakari Joenväärä, Petri S Mattila, Antti Aarni Mäkitie, Sanna H Lehtonen, Jaana Hagstrom, Suvi Renkonen
LRG1 and SDR16C5 protein expressions differ according to HPV status in oropharyngeal squamous cell carcinoma. Scientific reports 14 (1) (2024)
Reija Randén-Brady, Timo Carpén, Laura C Hautala, Tuomas Tolvanen, Caj Haglund, Sakari Joenväärä, Petri S Mattila, Antti Aarni Mäkitie, Sanna H Lehtonen, Jaana Hagstrom, Suvi Renkonen
LRG1 and SDR16C5 protein expressions differ according to HPV status in oropharyngeal squamous cell carcinoma. Scientific reports 14 (1) (2024)
Reija Randén-Brady, Timo Carpén, Laura C Hautala, Tuomas Tolvanen, Caj Haglund, Sakari Joenväärä, Petri S Mattila, Antti Aarni Mäkitie, Sanna H Lehtonen, Jaana Hagstrom, Suvi Renkonen
LRG1 and SDR16C5 protein expressions differ according to HPV status in oropharyngeal squamous cell carcinoma. Scientific reports 14 (1) (2024)
Rayan Mroueh, Aaro Haapaniemi, Timo Carpén, Eero Pukkala, Antti Aarni Mäkitie
Laryngeal cancer relative survival trends from 1972 to 2021 in the Nordic countries. Acta oncologica (Stockholm, Sweden) 63 (2024)
Amy Dickinson, Sakari Joenväärä, Tiialotta Tohmola, Jutta Renkonen, Petri S Mattila, Timo Carpén, Antti Aarni Mäkitie, Suvi Renkonen
Altered microheterogeneity at several N-glycosylation sites in OPSCC in constant protein expression conditions. FASEB bioAdvances 6 (1) (2023)
Amy Dickinson, Sakari Joenväärä, Tiialotta Tohmola, Jutta Renkonen, Petri S Mattila, Timo Carpén, Antti Aarni Mäkitie, Suvi Renkonen
Altered microheterogeneity at several N-glycosylation sites in OPSCC in constant protein expression conditions. FASEB bioAdvances 6 (1) (2023)
Timo Carpén, Stina M Syrjänen, Lauri Jouhi, Reija Randen-Brady, Caj Haglund, Antti Aarni Mäkitie, Petri S Mattila, Jaana Hagstrom
Epstein-Barr virus (EBV) and polyomaviruses are detectable in oropharyngeal cancer and EBV may have prognostic impact. Cancer immunology, immunotherapy : CII 69 (8) (2020)
Timo Carpén, Timo Sorsa, Lauri Jouhi, Taina Tervahartiala, Caj Haglund, Stina M Syrjänen, Jussi Tarkkanen, Hesham Mohamed, Antti Aarni Mäkitie, Jaana Hagstrom, Petri S Mattila
High levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) in the serum are associated with poor prognosis in HPV-negative squamous cell oropharyngeal cancer. Cancer immunology, immunotherapy : CII 68 (8) (2019)